PAR PHARM FDA Approval ANDA 089135

ANDA 089135

PAR PHARM

FDA Drug Application

Application #089135

Application Sponsors

ANDA 089135PAR PHARM

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL2.5MG0METHYCLOTHIAZIDEMETHYCLOTHIAZIDE

FDA Submissions

ORIG1AP1986-02-12
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1988-06-22
LABELING; LabelingSUPPL5AP1988-12-14
LABELING; LabelingSUPPL6AP1992-01-16
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-04-01

Submissions Property Types

ORIG1Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89135
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYCLOTHIAZIDE","activeIngredients":"METHYCLOTHIAZIDE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHYCLOTHIAZIDE","submission":"METHYCLOTHIAZIDE","actionType":"2.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.